The Division of Cancer Prevention (DCP) of the National Cancer Institute (NCI) is considering holding a workshop in the fall of 2021 on cancer screening clinical trials. The purpose of the workshop is in part to obtain information relevant to the potential creation of a new NCI-funded cancer screening clinical trials network focused on small-to-mid range trials. The workshop will focus on three areas as follows:
Practical issues in conducting small-to-medium sized cancer screening trials
Organ-site specific priorities for NCI-funded screening trials (lung, oral cavity, bladder, renal, prostate, breast, ovarian, endometrial, CRC, upper GI, pancreatic, liver)
Prior experience with cancer screening trial networks and necessary infrastructure for success
The tentative dates for the workshop are Oct 26 - 27th, 2021. The workshop will be virtual. We would like to gauge your availability and potential interest in being an active participant at this workshop.
Your topic area would be High Priority Screening Trials for Breast Cancer and your role would be as a Speaker.
Please email response to me, Mela Asefa mela.asefa@nih.gov Thank you for your consideration.
Sincerely,
Paul Pinsky, Ph.D. - NCI, DCP
Brandy Heckman-Stoddard, Ph.D., MPH - NCI, DCP
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| Author | Asefa, Mela (NIH/NCI) [E] |
| File Modified | 0000-00-00 |
| File Created | 2022-02-14 |